Jazz Pharmaceuticals Email & Phone number of top level executives

Jazz Pharmaceuticals

Pharmaceuticals

Jazz Pharmaceuticals is a biopharmaceutical company based in Dublin, Ireland with operations in the United States. Founded in 2003, the company specializes in developing and commercializing drugs in the areas of sleep medicine and oncology. Jazz Pharmaceuticals has established a strong presence in the US market, with several FDA-approved products in its portfolio. Its flagship product is Xyrem, a treatment for narcolepsy and cataplexy, which accounts for more than 75% of the company's revenue. Jazz Pharmaceuticals has a commitment to providing innovative therapies to address significant unmet medical needs, and is dedicated to making a positive impact on patient outcomes.